Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares

Kestra Medical Technologies, Ltd. (KMTS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference

Kestra Showcases Accelerated Innovation at HRS 2026

Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner

The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $304,050.00 in Stock

Kestra Medical Technologies, Ltd. (KMTS) Q3 2026 Earnings Call Transcript

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17

Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares

Short Interest in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Rises By 21.5%

KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery

Kestra Medical Technologies, Ltd. (KMTS) Presents at 44th Annual J.P.

Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6.1% – Here’s Why

Brian Daniel Webster Sells 15,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock

Traci Umberger Sells 10,500 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

Kestra Medical Technologies, Ltd. (KMTS) Q2 2026 Earnings Call Transcript

Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares

Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results

Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra's ASSURE Device

Kestra Medical Technologies to Present Late-Breaking ACE-PAS Trial Results at AHA 2025, Showcasing Next-Generation Wearable Defibrillator System

Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference

Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth

Kestra Showcases Cardiac Recovery System Platform at HFSA 2025, Redefining Sudden Cardiac Arrest Risk Management

Kestra Medical Technologies Appoints Dr. Elizabeth Kwo to Board of Directors

Kestra Medical Technologies, Ltd. to Report First Quarter Fiscal 2026 Financial Results

Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Kestra Medical Technologies, Ltd. to Report Fourth Quarter and Fiscal Year 2025 Results on July 15

Kestra Medical Technologies Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

Kestra Medical: Skipping A Heartbeat

Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering

Kestra Medical Technologies: A Potential Promising Public Offering

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering